Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP Cliff Donald Blessing sold 177 shares of the company’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total transaction of $18,648.72. Following the transaction, the executive vice president directly owned 12,361 shares of the company’s stock, valued at $1,302,354.96. This represents a 1.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Cliff Donald Blessing also recently made the following trade(s):
- On Tuesday, February 24th, Cliff Donald Blessing sold 350 shares of Addus HomeCare stock. The stock was sold at an average price of $107.14, for a total value of $37,499.00.
Addus HomeCare Trading Down 0.5%
Addus HomeCare stock opened at $103.53 on Friday. The business has a 50 day moving average price of $109.22 and a two-hundred day moving average price of $112.95. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $124.43. The stock has a market cap of $1.92 billion, a price-to-earnings ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91.
Institutional Investors Weigh In On Addus HomeCare
Key Stories Impacting Addus HomeCare
Here are the key news stories impacting Addus HomeCare this week:
- Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
- Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
- Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
- Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
- Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
- Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on ADUS. Royal Bank Of Canada reissued an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Wednesday. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday, February 23rd. Truist Financial set a $135.00 price objective on Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. TD Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Finally, Barclays lowered their price target on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus price target of $134.33.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
See Also
- Five stocks we like better than Addus HomeCare
- 3 Signs You May Want to Switch Financial Advisors
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- The Biggest IPO Ever… Open to Everyday Folks
- Read this or regret it forever
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
